Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Double-Blind, Placebo-Controlled Randomized Study of Bicifadine 200 Mg BID, Bicifadine 300 Mg BID, and Bicifadine 400 Mg BID in the Treatment of Chronic Low Back Pain

NCT00295711 is registered in ClinicalTrials.gov with DOV Pharmaceutical, Inc. as lead sponsor.

NCT NCT00295711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Double-Blind, Placebo-Controlled Randomized Study of Bicifadine 200 Mg BID, Bicifadine 300 Mg BID, and Bicifadine 400 Mg BID in the Treatment of Chronic Low Back Pain
Lead sponsor
DOV Pharmaceutical, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
Not reported
Enrollment
532
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low back pain